Immatics (IMTX) Cash from Operations (2019 - 2025)
Immatics' (IMTX) quarterly Cash from Operations came in at 68288612.79 in Q4 2025, down 9.28% year-on-year from 75277519.82 in Q4 2024, and down 30.68% quarter-over-quarter from 52256762.58 in Q3 2025.
Immatics (IMTX) Cash from Operations (2019 - 2025) Analysis & Trends
Immatics has disclosed Cash from Operations across 7 years of filings, most recently posting 68288612.79 for Q4 2025.
- Cash from Operations for Q4 2025 came in at 68288612.79, down 9.28% year-over-year; the trailing twelve-month figure through Dec 2025 was 200734820.13 (down 17.58% YoY), and the FY2025 annual result was 199554031.22, down 18.17% from the prior year.
- Cash from Operations came in at 68288612.79 for Q4 2025 at Immatics, down from 52256762.58 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 120527847.57 in Q1 2022 to a low of 68288612.79 in Q4 2025.
- The 5-year median for Cash from Operations is 30492948.76 (2021), against an average of 16828778.82.
- Across the five-year window, Cash from Operations surged 699.87% in 2022 and tumbled 397.17% in 2024, its largest moves.
- Immatics' Cash from Operations stood at 28900138.14 in 2021, then decreased by 11.02% to 32085759.39 in 2022, then jumped by 365.17% to 85082100.18 in 2023, then sank by 173.44% to 62487184.62 in 2024, then decreased by 9.28% to 68288612.79 in 2025.
- The last three Cash from Operations figures came in at 68288612.79 (Q4 2025), 52256762.58 (Q3 2025), and 44208685.61 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.43 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Immatics | 14.67 Bn | 14.67 Bn | - | -68.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -68.29 Mn |
| Dec 31, 2025 | -68.29 Mn |
| Sep 30, 2025 | -52.26 Mn |
| Sep 30, 2025 | -52.26 Mn |
| Jun 30, 2025 | -44.21 Mn |
| Jun 30, 2025 | -44.21 Mn |
| Mar 31, 2025 | -35.98 Mn |
| Mar 31, 2025 | -35.98 Mn |
| Dec 31, 2024 | -62.49 Mn |
| Dec 31, 2024 | -62.49 Mn |
| Sep 30, 2024 | -37.04 Mn |
| Sep 30, 2024 | -37.04 Mn |
| Jun 30, 2024 | -35.77 Mn |
| Jun 30, 2024 | -35.77 Mn |
| Mar 31, 2024 | -35.42 Mn |
| Mar 31, 2024 | -35.42 Mn |
| Dec 31, 2023 | 85.08 Mn |
| Dec 31, 2023 | 85.08 Mn |
| Sep 30, 2023 | -33.23 Mn |
| Sep 30, 2023 | -33.23 Mn |